Summary
Updated Aug 30, 2026
Raymond Prudo-Chlebosz is Director of Akari Therapeutics Plc (AKTX). 2 SEC Form 4 filings on record going back to 2024, most recently on 19 December 2025. Lifetime open-market purchases: $406K.
Recent Transactions
1Every recent SEC Form 4 transaction Raymond Prudo-Chlebosz has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Raymond Prudo-Chlebosz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M of AKTX open-market activity in the last 12 months
- Abizer Gaslightwala - $437K of AKTX open-market activity in the last 12 months
- Samir Rashmikant Patel - $344K of AKTX open-market activity in the last 12 months
- Sandip I. Patel - $162K of AKTX open-market activity in the last 12 months
- Robert B. Bazemore - $62K of AKTX open-market activity in the last 12 months
- Kameel D. Farag - $10K of AKTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Raymond Prudo-Chlebosz?
Raymond Prudo-Chlebosz is a corporate insider, tracked as Director of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Raymond Prudo-Chlebosz last file a Form 4?
The most recent primary Form 4 on record is dated 19 December 2025, one of 2 filings going back to 2024.
Has Raymond Prudo-Chlebosz been buying or selling stock?
Recorded transactions: 4 open-market purchases ($406K) and 0 open-market sales across all tracked filings.
Where can I see all of Raymond Prudo-Chlebosz's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Raymond Prudo-Chlebosz and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
